NCT02110134View on ClinicalTrials.gov

A Study of the RevLite Laser System for the Treatment of Refractory Mixed Type Melasma

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Melasma
Interventions
DEVICE

Revlite Laser System with hydroquinone skin care regimen

Revlite Laser System with hydroquinone skin care regimen for the Treatment of Melasma

OTHER

Hydroquinone skin care regimen

Hydroquinone skin care regimen for the Treatment of Melasma

Trial Locations (1)

10028

NY Laser and Skin Care, New York

Sponsors

Lead Sponsor

Cynosure, Inc.
All Listed Sponsors
lead

Cynosure, Inc.

INDUSTRY

NCT02110134 - A Study of the RevLite Laser System for the Treatment of Refractory Mixed Type Melasma | Biotech Hunter | Biotech Hunter